Series c redeemable preferred stock, 0.00001 par value, 10,000 shares authorized, 7 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
1,724
1,724
1,724
1,724
Common stock, 0.00001 par value, 250,000,000 shares authorized at june 30, 2026 and december 31, 2025 3,793,676 and 31,201 shares issued at june 30, 2026 and december 31, 2025, respectively 3,793,673 and 31,198 shares outstanding at june 30, 2026 and december 31, 2025, respectively
38
27
15
15
Additional paid-in capital
152,959,715
148,242,874
147,835,989
141,431,240
Treasury stock, at cost 3 shares of common stock at june 30, 2026 and december 31, 2025
625,791
625,791
625,791
625,791
Accumulated deficit
-138,296,736
-135,429,433
-131,214,558
-136,884,245
Accumulated other comprehensive loss
-568,717
-441,200
-231,028
-547,098
Preferred stock, value issued-Series DPreferred Stock
-
-
0
-
Preferred stock, value issued-Series EPreferred Stock
-
-
0
-
Due from shareholders
-
-
0
-
Total stockholders equity
13,468,509
11,746,477
15,764,627
3,374,121
Total liabilities, convertible preferred stock, and stockholders equity
16,426,341
14,832,086
24,926,638
19,678,868
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.